Cases 1 - 10 of 36
Genentech, Inc. et al v. Biogen MA Inc. et al
as 1:2023cv11573
Plaintiff:
Genentech, Inc., Hoffmann-Laroche, Inc. and Chugai Pharmaceutical Co., Ltd.
Defendant:
Biogen MA Inc. and Bio-Thera Solutions, Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Sandoz Inc. et al
as 1:2022cv01190
Counter Defendant:
Biogen Inc. and Biogen MA Inc.
Defendant:
Sandoz Inc., Sandoz GmbH, Sandoz International GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen MA Inc. v. Sun Pharmaceutical Industries Limited et al
as 1:2020cv01159
Defendant:
Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited
Plaintiff:
Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Banner Life Sciences LLC
as 1:2018cv00582
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Banner Life Sciences LLC
Counter_claimant:
Banner Life Sciences LLC
Counter_defendant:
Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen MA Inc. et al v. Iancu
as 1:2018cv00147
Plaintiff:
Biogen MA Inc. and Biogen International Neuroscience GmbH
Defendant:
Andrei Iancu
Cause Of Action: 35 U.S.C. § 154
Biogen MA Inc. v. Caribe Holdings (Cayman) Co. Ltd. et al
as 1:2018cv00121
Plaintiff:
Biogen MA Inc.
Defendant:
Caribe Holdings (Cayman) Co. Ltd. , DBA Puracap Caribe and Puracap International LLC
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Zydus Pharmaceuticals (USA) Inc.
as 1:2017cv00954
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Zydus Pharmaceuticals (USA) Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Sawai USA, Inc. et al
as 1:2017cv00875
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Sawai USA, Inc. and Sawai Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Par Pharmaceutical, Inc.
as 1:2017cv00873
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GMBH et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00116
Plaintiff:
Biogen International GMBH and Biogen MA, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
